imiquimod has been researched along with Scalp Dermatoses in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (52.38) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, FR; Raza, SA | 1 |
| Carr, DR; Kaffenberger, JA; Yanes, DA | 1 |
| Gonzalez, H; Haedersdal, M; Halldin, C; Sandberg, C; Sørensen, SS; Togsverd-Bo, K; Wennberg, AM; Wulf, HC | 1 |
| Borgia, F; Cannavò, SP; Giuffrida, R | 1 |
| Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Kouloubis, N; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Steijlen, PM; van Pelt, HPA | 1 |
| Berrios, R; Hutchens, KA; Millsop, JW; Trinh, N; Tung, R; Winterfield, L | 1 |
| Alomar, A; Aractingi, S; Dakovic, R; Dirschka, T; Gupta, G; Peris, K; Stockfleth, E | 1 |
| Alarcon, I; Sibbring, GC; Stockfleth, E | 1 |
| Barbuzza, O; Guarneri, B; Vaccaro, M | 1 |
| Botella-Estrada, R; Guillen, C; Hueso, L; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillen, C | 1 |
| Cahill, J; Campbell, J; Crouch, R; Cumming, S; Foley, P; Harrison, S; Merlin, K | 1 |
| Bieber, T; Gerdsen, R; Petrow, W; Uerlich, M; Wenzel, J | 1 |
| Greene, RJ; Harrison, LI; Kurup, S; Marbury, TC; McKane, S; Owens, ML; Skinner, SL | 1 |
| Davey, V; Gupta, AK; Mcphail, H | 1 |
| Dika, E; Fanti, PA; Miscial, C; Vaccari, S; Varotti, C | 1 |
| Tanghetti, E; Werschler, P | 1 |
| Dixon, A | 1 |
| Alomar, A; Bichel, J; McRae, S | 1 |
| Dinehart, S; Fielder, S; Fox, TL; Jorizzo, J; Lee, JH; Ling, M; Matheson, R; McRae, S; Moore, JK | 1 |
| Anders, M; Birmachu, W; Bulbulian, BJ; Jin, J; Lee, J; Miller, RL; Raghavan, S; Slade, HB; Storey, L; Torres, A | 1 |
| Benninghoff, B; Christophers, E; Meyer, T; Stockfleth, E | 1 |
3 review(s) available for imiquimod and Scalp Dermatoses
| Article | Year |
|---|---|
Erythema multiforme as a reaction to imiquimod 5% cream.
Topics: Adjuvants, Immunologic; Aminoquinolines; Erythema Multiforme; Glucocorticoids; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Scalp Dermatoses | 2017 |
New Topical Treatment Options for Actinic Keratosis: A Systematic Review.
Topics: Administration, Cutaneous; Aminoquinolines; Dermatologic Agents; Diterpenes; Drug Combinations; Facial Dermatoses; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Randomized Controlled Trials as Topic; Salicylic Acid; Scalp Dermatoses; Skin; Treatment Outcome | 2016 |
Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
Topics: Adjuvants, Immunologic; Aminoquinolines; Clinical Trials, Phase III as Topic; Confidence Intervals; Facial Dermatoses; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Keratosis; Ointments; Photosensitivity Disorders; Scalp Dermatoses; Time Factors | 2005 |
10 trial(s) available for imiquimod and Scalp Dermatoses
| Article | Year |
|---|---|
Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial.
Topics: Aged; Aminolevulinic Acid; Drug Eruptions; Facial Dermatoses; Female; Hand Dermatoses; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Treatment Outcome | 2018 |
Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Follow-Up Studies; Gels; Humans; Imiquimod; Intention to Treat Analysis; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Proportional Hazards Models; Scalp Dermatoses; Single-Blind Method; Skin Cream; Treatment Outcome | 2019 |
Efficacy of imiquimod 3.75% from Lmax according to the number of actinic keratosis lesions.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Double-Blind Method; Face; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Scalp; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2015 |
A randomized comparative study of tolerance and satisfaction in the treatment of actinic keratosis of the face and scalp between 5% imiquimod cream and photodynamic therapy with methyl aminolaevulinate.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Aminolevulinic Acid; Aminoquinolines; Child; Child, Preschool; Facial Dermatoses; Female; Humans; Imiquimod; Infant; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp Dermatoses; Young Adult | 2011 |
A comparison of cryotherapy and imiquimod for treatment of actinic keratoses: lesion clearance, safety, and skin quality outcomes.
Topics: Adjuvants, Immunologic; Aged; Aminoquinolines; Cryotherapy; Facial Dermatoses; Female; Follow-Up Studies; Humans; Imiquimod; Keratosis, Actinic; Male; Scalp Dermatoses; Treatment Outcome | 2011 |
Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms.
Topics: Absorption; Adjuvants, Immunologic; Administration, Topical; Aged; Aminoquinolines; Arm; Facial Dermatoses; Female; Hand; Humans; Imiquimod; Keratosis; Male; Middle Aged; Scalp Dermatoses | 2004 |
Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
Topics: Administration, Topical; Adult; Aminoquinolines; Disease Management; Erythema; Facial Dermatoses; Fluorouracil; Humans; Imiquimod; Keratosis; Scalp Dermatoses; Treatment Outcome | 2007 |
Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the head.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Double-Blind Method; Female; Humans; Imiquimod; Interferon Inducers; Keratosis; Male; Middle Aged; Ointments; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms; Sunlight; Treatment Outcome | 2007 |
Vehicle-controlled, double-blind, randomized study of imiquimod 5% cream applied 3 days per week in one or two courses of treatment for actinic keratoses on the head.
Topics: Adult; Aminoquinolines; Double-Blind Method; Drug Administration Schedule; Facial Dermatoses; Female; Humans; Imiquimod; Keratosis; Male; Ointments; Photosensitivity Disorders; Recurrence; Scalp Dermatoses; Treatment Outcome | 2007 |
Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Gene Expression; Humans; Imiquimod; Keratosis; Male; Middle Aged; Oligonucleotide Array Sequence Analysis; Photosensitivity Disorders; Scalp Dermatoses; Toll-Like Receptor 7; Treatment Outcome | 2007 |
8 other study(ies) available for imiquimod and Scalp Dermatoses
| Article | Year |
|---|---|
Comparison of efficacy of field treatments for actinic keratoses.
Topics: Adult; Aminolevulinic Acid; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Scalp Dermatoses | 2020 |
Two cases of erosive pustular dermatosis of the scalp occurring after topical 3.75% imiquimod for actinic keratoses.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Clobetasol; Dermatologic Agents; Drug Eruptions; Humans; Imiquimod; Keratosis, Actinic; Male; Scalp; Scalp Dermatoses; Treatment Outcome | 2019 |
Resolution of recalcitrant pyogenic granuloma with laser, corticosteroid, and timolol therapy.
Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Adult; Aminoquinolines; Anti-Bacterial Agents; Biopsy; Chemotherapy, Adjuvant; Combined Modality Therapy; Drug Therapy, Combination; Granuloma, Pyogenic; Humans; Imiquimod; Laser Therapy; Lasers, Dye; Lasers, Solid-State; Male; Recurrence; Scalp Dermatoses; Timolol; Triamcinolone Acetonide | 2014 |
Erosive pustular dermatosis of the scalp following treatment with topical imiquimod for actinic keratosis.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Keratosis, Actinic; Male; Risk Assessment; Scalp Dermatoses; Severity of Illness Index; Skin Diseases, Papulosquamous | 2009 |
Successful treatment of chronic discoid lupus erythematosus of the scalp with imiquimod.
Topics: Administration, Topical; Aminoquinolines; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Lupus Erythematosus, Discoid; Middle Aged; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2002 |
Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Drug Eruptions; Humans; Imiquimod; Keratosis; Male; Ointments; Psoriasis; Scalp Dermatoses | 2006 |
Treating actinic keratoses with imiquimod.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Facial Dermatoses; Humans; Imiquimod; Keratosis; Male; Middle Aged; Photosensitivity Disorders; Scalp Dermatoses; Skin Neoplasms | 2007 |
Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Drug Administration Schedule; Follow-Up Studies; Humans; Imiquimod; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Precancerous Conditions; Recurrence; Scalp Dermatoses; Skin Neoplasms | 2001 |